{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:20:04Z","timestamp":1783383604268,"version":"3.54.6"},"reference-count":16,"publisher":"Oceanside Publications Inc.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:p>Genetically determined defects of T-cell development comprise a heterogeneous group of conditions characterized by peripheral T-cell lymphopenia due to impaired intrathymic differentiation of T-cell progenitors. Collectively, these conditions are typically referred to as severe combined immune deficiency (SCID). In some cases (leaky SCID), residual function of the defective gene allows partial T-cell development. The vast majority of SCID disorders are due to genetic defects that affect the T-cell differentiation potential of hematopoietic stem cells, through a variety of mechanisms. However, some forms of SCID reflect impaired development or function of thymic stromal cells. A lack of peripheral T cells leads to increased susceptibility to severe infections since early in life. SCID is inevitably fatal unless immune reconstitution is achieved, most often through hematopoietic cell transplantation. Enzyme replacement therapy, gene therapy, and thymus implantation represent other forms of treatment in selected cases. The availability of newborn screening has greatly facilitated prompt recognition of SCID, which allows statistically significant improvement in survival after hematopoietic cell transplantation.<\/jats:p>","DOI":"10.2500\/aap.2024.45.240028","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T04:31:59Z","timestamp":1726720319000},"page":"326-331","source":"Crossref","is-referenced-by-count":4,"title":["Genetically-determined defects of T cell development"],"prefix":"10.2500","volume":"45","author":[{"given":"Luigi D.","family":"Notarangelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1355","reference":[{"key":"B1","first-page":"1","article-title":"Overview of the immune system","volume-title":"Paul\u2019s Fundamental Immunology","author":"Flajnik","year":"2023"},{"key":"B2","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"B3","doi-asserted-by":"crossref","first-page":"15061","DOI":"10.1038\/nrdp.2015.61","article-title":"Severe combined immunodeficiencies and related disorders","volume":"1","author":"Fischer","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"B4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/imr.13306","article-title":"Primary and secondary defects of the thymus","volume":"322","author":"Dinges","year":"2024","journal-title":"Immunol Rev"},{"key":"B5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaci.2022.10.022","article-title":"The diagnosis of severe combined immunodeficiency (SCID): the Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 definitions","volume":"151","author":"Dvorak","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2008.09.037","article-title":"Omenn syndrome: inflammation in leaky severe combined immunodeficiency","volume":"122","author":"Villa","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10875-022-01418-y","article-title":"Clinical practice guidelines for the immunological management of chromosome 22q11.2 deletion syndrome and other defects in thymic development","volume":"43","author":"Mustillo","year":"2023","journal-title":"J Clin Immunol"},{"key":"B8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/imr.12729","article-title":"Newborn screening for severe combined immunodeficiency and T-cell lymphopenia","volume":"287","author":"Puck","year":"2019","journal-title":"Immunol Rev"},{"key":"B9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/imr.13310","article-title":"Severe combined immunodeficiency diagnosis and genetic defects","volume":"322","author":"Aranda","year":"2024","journal-title":"Immunol Rev"},{"key":"B10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jaci.2017.01.005","article-title":"Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening","volume":"139","author":"Dorsey","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2500\/aap.2024.45.240069","article-title":"Hematopoietic stem cell transplantation for primary immunodeficiency","volume":"45","author":"Alsaati","year":"2024","journal-title":"Allergy Asthma Proc"},{"key":"B12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0140-6736(23)00731-6","article-title":"Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: A 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium","volume":"402","author":"Thakar","year":"2023","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcome for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2500\/aap.2024.45.240054","article-title":"Immunodeficiency: Gene therapy for primary immune deficiency","volume":"45","author":"Afzal","year":"2024","journal-title":"Allergy Asthma Proc"},{"key":"B15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.hoc.2022.03.010","article-title":"Gene therapy for inborn errors of immunity: severe combined immunodeficiencies","volume":"36","author":"Chetty","year":"2022","journal-title":"Hematol Oncol Clin North Am"},{"key":"B16","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaci.2021.06.028","article-title":"Experience with cultured thymus tissue in 105 children","volume":"149","author":"Markert","year":"2022","journal-title":"J Allergy Clin Immunol"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2024\/00000045\/00000005\/art00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T10:00:41Z","timestamp":1732788041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2024.45.240028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9,1]]}},"alternative-id":["1088-5412(20240901)45:5L.326;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2024.45.240028","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}